Live Chat

CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 74% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

Handelen AstraZeneca AZN

AstraZeneca live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

Nieuws

Info

Spread

73.63

Spread (%)

0.6186 %

Hefboom

1:5

Dagrente kopen

-0.0590 %

Dagrente verkopen

-0.0299 %

Valuta

PNC

Openingstijden

Markt gesloten

Maandag

07:01 - 10:59

Dinsdag

07:01-10:59

Dinsdag

11:03-15:29

Woensdag

07:01-10:59

Woensdag

11:03-15:29

Donderdag

07:01-10:59

Donderdag

11:03-15:29

Vrijdag

07:01-10:59

Vrijdag

11:03-15:29

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

167934820352

Uitstaande aandelen

1550300032

Datum winstcijfer (volgende)

0000-00-00

Div. rend.

Ex-dividenddatum

2024-08-08

Jaarlijks verwachte dividendpercentage

2.34

Jaarlijks verwachte dividendrendement

0.0231

Winst per aandeel

3.18

Meer informatie over dit instrument

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten

Laatste marktnieuws

Blijf op de hoogte van het laatste financiële nieuws uit de hele wereld.

Woensdag, 6 November 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Dinsdag, 5 November 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Dinsdag, 5 November 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Dinsdag, 5 November 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Dinsdag, 5 November 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Dinsdag, 5 November 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Maandag, 4 November 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Maandag, 4 November 2024

US election: What will happen to tesla stock if Trump wins?

Trustpilot
Live Chat